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Editorial
Disease management programs in the USA and Europe
are comparable (yet?) different
I recently attended the Third Colloqium 2006 of the
Disease Management Association of America (DMAA)
in Philadelphia. Over three days, more than 300
researchers, health care providers and policy makers
followed nearly eighty speakers on many aspects of
Disease Management Programs (DMPs). I was the
only visitor from Europe. Being there I had feelings of
coming home: DMPs are in some aspects comparable
with those in Europe. I had also the sensation that I
had arrived on another planet: DMPs are in other
aspects totally different. Based on the experiences in
Philadelphia, I have made a comparison between the
USA and Europe w1x. This is, of course, only a com-
parison based on a three-day congress visit.
American and European disease management pro-
grams are focused on the same chronic conditions:
diabetes (Greene), asthma (Tinkelman), coronary
heart diseases (Oetgen, Shults) and heart failure
(Barbell). On both continents, the first emphasis is on
promotion of self management of patients by means
of individual and group education and forms of feed-
back to the patients (Hunsaker, Steinberg). Another
common aspect is the objective to reduce hospital
admissions and emergency visits (Duncan, Lewis).
Thirdly, a strong coordination exists in both American
and European DMPs between the different profession-
als in primary health care and hospital care. Various
mechanisms coordinate the DMPs: protocols, stan-
dards, case managers, and joint patient records
(Cook). Modern health technology plays an important
role into archiving and forwarding health information
via the internet (Gill, Kardos).
One big difference exists between the USA and
Europe. There, disease related integrated care is pro-
vided by independent, mostly commercial disease
management programs. They do their work instead of
regular primary health care and regular hospitals. In
Philedelphia, this approach was at the centre of the
congress. Not all speakers agreed with this outcarved,
independent approach. Medicare’s health care inno-
vator, Linda Mango, preferred to embed DMPs within
the regular structures, because persons with one
chronic condition (still?) do need all types of services.
In contrast, Wallstreet broker Brooks O’Neil has lost
all trust in carers as usual, in regular primary care and
hospitals, and wants to invest as much as he can in
commercial DMPs. He sees DMPs as a tool for a rev-
olution to replace ordinary fragmented working doctors
and hospitals.
During the colloquium a new type of economic evalu-
ation was shown. whereby the Cost Effectiveness
Analysis of single interventions is no longer important.
At the core of the economic evaluation are the PMPM
costs: the costs of care Per Member Per Month. When
they are lower than the PMPM costs in a fragmented
setting, for instance 10%, then there is a Return On
Investment (ROI) of 10%. Linden and Lewis gave an
overview of ROIs during the colloquium in Philadel-
phia. They emphasised that in economic evaluation, a
lot of subjectivity is hidden. Linda Mango agreed with
this opinion and asked for standardisation of economic
evaluation of DMPs.
Who is the best: USA or Europe?
As editor in chief of this Journal, in the past five years
I have seen many descriptions of European integrated
care projects, which are comparable with American
disease management programs. For instance, I
remember the papers of Steuten w2x, Eijkelberg w3x
Dutch disease management, the paper on English
stroke patients by Hamilton w4x and the paper of Hel-
lesø w5x on ICT support during hospital discharge of
Norwegian hospital patients.
After a three-day visit to the Disease Management
Colloquium 2006, the only conclusion is that the Amer-
icans can learn from the Europeans and vice versa.
October and November 2006 and January 2007 are
busy months for disease management and integrated
care promoters. In these months European profes-
sionals, researchers and policy makers will meet each
other in Utrecht, London and Bonn. All meetings are
organised under the umbrella of the International Net-
work of Integrated Care. Hopefully, we will also meet
many American disease management promoters here
and hopefully, in 2007, I will not be the only European
at the fourth Disease Management Colloquium in
Philadelphia.
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